Acute and subchronic effects of bilastine (20 and 40mg) and hydroxyzine (50mg) on actual driving performance in healthy volunteers.
Phase of Trial: Phase II
Latest Information Update: 18 Jan 2012
At a glance
- Drugs Bilastine; Hydroxyzine
- Indications Allergic rhinitis; Rhinoconjunctivitis
- Focus Pharmacodynamics
- 18 Jan 2012 New trial record